Pila Pharma Q4’21: Approaching the Next Step - Redeye

Redeye leaves its comment on Pila Pharma following the announcement of its year-end report. The figures in the report were largely in line with our expectations, and we make no major amendments to our forecasts following today’s announcement.

Länk till analysen i sin helhet: https://www.redeye.se/research/833776/pila-pharma-q421-approaching-the-next-step?utm_source=finwire&utm_medium=RSS